卵巣癌治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Ovarian Cancer Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03969 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、卵巣癌治療の世界市場について調査・分析し、卵巣癌治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（PARP、PD-L1、血管新生阻害剤）、用途別（病院、研究）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の卵巣癌治療市場動向 ・主要企業別マーケットシェア ・卵巣癌治療の種類別市場規模2014-2019 （PARP、PD-L1、血管新生阻害剤） ・卵巣癌治療の用途別市場規模2014-2019 （病院、研究） ・卵巣癌治療の北米市場：主要企業・種類別/用途別市場規模 ・卵巣癌治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・卵巣癌治療の中国市場：主要企業・種類別/用途別市場規模 ・卵巣癌治療の日本国内市場：主要企業・種類別/用途別市場規模 ・卵巣癌治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・卵巣癌治療のインド市場：主要企業・種類別/用途別市場規模 ・卵巣癌治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol Myers Squibb Company、Eli Lilly and Company、GlaxoSmithKline Plc、Janssen Pharmaceuticals、Genentech Inc.、Astra Zeneca、Boehringer Ingelheim GmbH、Hoffmann La Roche Ltd.） ・卵巣癌治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.In 2018, the global Ovarian Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ovarian Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ovarian Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals
Genentech Inc.
Astra Zeneca
Boehringer Ingelheim GmbH
Hoffmann La Roche Ltd.

Market segment by Type, the product can be split into
PARP
PD-L1
Angiogenesis Inhibitors

Market segment by Application, split into
Hosptial
Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ovarian Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Ovarian Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ovarian Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 PARP
1.4.3 PD-L1
1.4.4 Angiogenesis Inhibitors
1.5 Market by Application
1.5.1 Global Ovarian Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hosptial
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ovarian Cancer Therapeutics Market Size
2.2 Ovarian Cancer Therapeutics Growth Trends by Regions
2.2.1 Ovarian Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Ovarian Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ovarian Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Ovarian Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Ovarian Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ovarian Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Ovarian Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Ovarian Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Ovarian Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ovarian Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Ovarian Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Ovarian Cancer Therapeutics Market Size (2014-2019)
5.2 Ovarian Cancer Therapeutics Key Players in United States
5.3 United States Ovarian Cancer Therapeutics Market Size by Type
5.4 United States Ovarian Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Ovarian Cancer Therapeutics Market Size (2014-2019)
6.2 Ovarian Cancer Therapeutics Key Players in Europe
6.3 Europe Ovarian Cancer Therapeutics Market Size by Type
6.4 Europe Ovarian Cancer Therapeutics Market Size by Application

7 China
7.1 China Ovarian Cancer Therapeutics Market Size (2014-2019)
7.2 Ovarian Cancer Therapeutics Key Players in China
7.3 China Ovarian Cancer Therapeutics Market Size by Type
7.4 China Ovarian Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Ovarian Cancer Therapeutics Market Size (2014-2019)
8.2 Ovarian Cancer Therapeutics Key Players in Japan
8.3 Japan Ovarian Cancer Therapeutics Market Size by Type
8.4 Japan Ovarian Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ovarian Cancer Therapeutics Market Size (2014-2019)
9.2 Ovarian Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Ovarian Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Ovarian Cancer Therapeutics Market Size by Application

10 India
10.1 India Ovarian Cancer Therapeutics Market Size (2014-2019)
10.2 Ovarian Cancer Therapeutics Key Players in India
10.3 India Ovarian Cancer Therapeutics Market Size by Type
10.4 India Ovarian Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Ovarian Cancer Therapeutics Market Size (2014-2019)
11.2 Ovarian Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Ovarian Cancer Therapeutics Market Size by Type
11.4 Central & South America Ovarian Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bristol Myers Squibb Company
12.1.1 Bristol Myers Squibb Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ovarian Cancer Therapeutics Introduction
12.1.4 Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.1.5 Bristol Myers Squibb Company Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ovarian Cancer Therapeutics Introduction
12.2.4 Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.2.5 Eli Lilly and Company Recent Development
12.3 GlaxoSmithKline Plc
12.3.1 GlaxoSmithKline Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ovarian Cancer Therapeutics Introduction
12.3.4 GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Plc Recent Development
12.4 Janssen Pharmaceuticals
12.4.1 Janssen Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ovarian Cancer Therapeutics Introduction
12.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.4.5 Janssen Pharmaceuticals Recent Development
12.5 Genentech Inc.
12.5.1 Genentech Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ovarian Cancer Therapeutics Introduction
12.5.4 Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.5.5 Genentech Inc. Recent Development
12.6 Astra Zeneca
12.6.1 Astra Zeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ovarian Cancer Therapeutics Introduction
12.6.4 Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.6.5 Astra Zeneca Recent Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ovarian Cancer Therapeutics Introduction
12.7.4 Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.7.5 Boehringer Ingelheim GmbH Recent Development
12.8 Hoffmann La Roche Ltd.
12.8.1 Hoffmann La Roche Ltd. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ovarian Cancer Therapeutics Introduction
12.8.4 Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2014-2019)
12.8.5 Hoffmann La Roche Ltd. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Ovarian Cancer Therapeutics Key Market Segments
Table Key Players Ovarian Cancer Therapeutics Covered
Table Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Ovarian Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure PARP Figures
Table Key Players of PARP
Figure PD-L1 Figures
Table Key Players of PD-L1
Figure Angiogenesis Inhibitors Figures
Table Key Players of Angiogenesis Inhibitors
Table Global Ovarian Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hosptial Case Studies
Figure Research Case Studies
Figure Ovarian Cancer Therapeutics Report Years Considered
Table Global Ovarian Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Ovarian Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Ovarian Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Ovarian Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Ovarian Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Ovarian Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Ovarian Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Ovarian Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Ovarian Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Ovarian Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Ovarian Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ovarian Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Ovarian Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Ovarian Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Ovarian Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Ovarian Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Ovarian Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Ovarian Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table United States Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table Europe Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table China Ovarian Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table China Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table Japan Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table India Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table India Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Ovarian Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Ovarian Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Ovarian Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Ovarian Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Ovarian Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Ovarian Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Ovarian Cancer Therapeutics Market Share by Application (2014-2019)
Table Bristol Myers Squibb Company Company Details
Table Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Bristol Myers Squibb Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Bristol Myers Squibb Company Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Plc Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table GlaxoSmithKline Plc Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Genentech Inc. Company Details
Table Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Genentech Inc. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Genentech Inc. Recent Development
Table Astra Zeneca Company Details
Table Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Astra Zeneca Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Astra Zeneca Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Boehringer Ingelheim GmbH Recent Development
Table Hoffmann La Roche Ltd. Company Details
Table Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Hoffmann La Roche Ltd. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2014-2019)
Table Hoffmann La Roche Ltd. Recent Development
Table Global Ovarian Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Ovarian Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Ovarian Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Ovarian Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Ovarian Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Ovarian Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Ovarian Cancer Therapeutics Market Size by Product in 2025
Table Global Ovarian Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Ovarian Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Ovarian Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---